andrew-barr
31 March 2022Insurance

Miller swoops for former Marsh credit and political risk broker

Specialist re/insurance broker  Miller has hired a former Marsh executive to bolster its credit and political risk expertise.

Andrew Barr (pictured) joins Miller from Texel Finance in London, where he worked as a credit & political risk (CPRI) insurance broker for the last four years.

Barr previously worked at global broker Marsh for nearly seven years, most recently as vice president, CPRI.

He specialises in helping financial institution (FI) clients obtain risk mitigating and regulatory compliant credit insurance solutions, as well as political risk insurance for both FI and corporate clients.

Ben Gibbons, Miller's head of CPRI (London), said: “We welcome Andrew to the team. His experience, expertise and judgement, particularly working with financial institutions, adds further depth to an already talented team. Our priority is to build on Miller’s 25-year track record as specialists in CPRI and serve the continually evolving needs of our clients.”

Barr commented: “I’m excited to be joining Miller at a transformational time for the company. Under independent ownership the focus on growth is clear. I look forward to working alongside my many talented colleagues across Miller and supporting our clients with insurance solutions that help facilitate tangible benefit to the real economy.”

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Insurance
24 September 2026   Danish insurers face 2026 hit from workers’ comp ruling, warns Moody’s.
Insurance
24 September 2026   Association’s 27th president to promote marine insurance as a career choice.
Insurance
24 September 2026   Move comes as employers face rising pharmacy spend and complex medical claims.